Myriad Genetics (MYGN) EBT Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) EBT Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 283.91 Mn | 159.51 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.22% |
| Dec 31, 2025 | 37.60% |
| Sep 30, 2025 | 35.42% |
| Jun 30, 2025 | -11.76% |
| Mar 31, 2025 | 25.84% |
| Dec 31, 2024 | -27.95% |
| Sep 30, 2024 | 1.01% |
| Jun 30, 2024 | -37.03% |
| Mar 31, 2024 | -58.01% |
| Dec 31, 2023 | -61.46% |
| Sep 30, 2023 | -139.32% |
| Jun 30, 2023 | -53.24% |
| Mar 31, 2023 | -42.88% |
| Dec 31, 2022 | -62.42% |
| Sep 30, 2022 | -20.41% |
| Jun 30, 2022 | -24.57% |
| Mar 31, 2022 | -45.64% |
| Dec 31, 2021 | -40.81% |
| Sep 30, 2021 | 52.03% |
| Jun 30, 2021 | 50.84% |